Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Dig Dis
    April 2024
  1. TEUFEL A, Kudo M, Qian Y, Daza J, et al
    Current Trends and Advancements in the Management of Hepatocellular Carcinoma.
    Dig Dis. 2024 Apr 10. doi: 10.1159/000538815.
    >> Share

    March 2024
  2. LEMMER P, Rohr LC, Henning M, Bulut K, et al
    Liver stiffness determined by transient elastography is a simple and highly accurate predictor for presence of liver cirrhosis in clinical routine.
    Dig Dis. 2024 Mar 25. doi: 10.1159/000538426.
    >> Share

    January 2024
  3. WU PS, Hsieh YC, Lee PC, Yang TC, et al
    Mac-2 Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients.
    Dig Dis. 2024 Jan 12. doi: 10.1159/000535325.
    >> Share

  4. MANSOUR N, Sirtl S, Angele MK, Wildgruber M, et al
    Management of Sinistral Portal Hypertension After Pancreaticoduodenectomy.
    Dig Dis. 2024 Jan 5. doi: 10.1159/000535774.
    >> Share

  5. UOJIMA H, Sakaguchi Y, Gotoh K, Satoh T, et al
    Metabolic Dysfunction-Associated Fatty Liver Disease on Distinct Microbial Communities at the Bacterial Phylum Level.
    Dig Dis. 2024;42:61-69.
    >> Share

  6. LI H, Yu S, Chen L, Liu H, et al
    Immunomodulatory Role of Mesenchymal Stem Cells in Liver Transplantation: Status and Prospects.
    Dig Dis. 2024;42:41-52.
    >> Share

    September 2023
  7. TAN D, Chan KE, Wong ZY, Ng CH, et al
    Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of NASH between Males and Females.
    Dig Dis. 2023 Sep 13. doi: 10.1159/000533946.
    >> Share

    July 2023
  8. KEKLIKKIRAN C, Stepanova M, Younossi Z, Yilmaz Y, et al
    Can Frequent Toothbrushing Reduce the Risk of Cirrhosis among Patients with Non-alcoholic Fatty Liver Disease? Hints from a Registry-based Study.
    Dig Dis. 2023 Jul 26. doi: 10.1159/000531981.
    >> Share

    June 2023
  9. THORMANN M, Heitmann F, Wrobel V, Heinze C, et al
    Interstitial brachytherapy for hepatocellular carcinoma: Analysis of prognostic factors for overall survival and progression free survival and application of a risk stratification model.
    Dig Dis. 2023 Jun 29. doi: 10.1159/000531732.
    >> Share

  10. TAMURA Y, Asaoka Y, Takeuchi A, Matsumoto K, et al
    Long-Term Prognosis and Related Factors in Patients with Cirrhosis Treated with Balloon-Occluded Retrograde Transvenous Obliteration.
    Dig Dis. 2023 Jun 29:1-9. doi: 10.1159/000530781.
    >> Share

  11. CHEN Q, Zhong R, Wang Y, Kui Y, et al
    The Albumin-Bilirubin Score as a Predictor of Liver-Related Mortality in Primary Biliary Cholangitis with Compensated Cirrhosis.
    Dig Dis. 2023 Jun 15. doi: 10.1159/000531557.
    >> Share

    May 2023
  12. QUEK J, Tan DJH, Chan KE, Lim WH, et al
    Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Systematic Review and Meta-Analysis.
    Dig Dis. 2023 May 11:1. doi: 10.1159/000531016.
    >> Share

    April 2023
  13. WANG SQ, Zhan YQ, Hu X, Zhuang YP, et al
    Anemia is associated with disease severity, hepatic complications, and progression of Wilson disease: a retrospective cohort study.
    Dig Dis. 2023 Apr 5. doi: 10.1159/000530473.
    >> Share

    March 2023
  14. GARCIA EM, Nerurkar SN, Tan EX, Tan SY, et al
    Characteristics and Outcomes of Elderly Hepatocellular Carcinoma Patients following Surgical Resection: Systematic Review and Meta-analysis.
    Dig Dis. 2023 Mar 13. doi: 10.1159/000530101.
    >> Share

    January 2023
  15. SCHMIDERER A, Zoller H, Niederreiter M, Effenberger M, et al
    Liver transplantation after successful downstaging of a locally advanced hepatocellular carcinoma with systemic therapy.
    Dig Dis. 2023 Jan 16. doi: 10.1159/000529023.
    >> Share

  16. QIAN Y, Liu B, Weiss C, Zhu X, et al
    Distance Matters: Correlation of Hepatocellular Carcinoma Nodule Distance to Overall Survival.
    Dig Dis. 2023;41:107-114.
    >> Share

  17. CHENG P, Li Z, Fu Z, Jian Q, et al
    Small-For-Size Syndrome and Graft Inflow Modulation Techniques in Liver Transplantation.
    Dig Dis. 2023;41:250-258.
    >> Share

  18. KREIMEYER H, Buechter M, Best J, Gieseler RK, et al
    Performance of the Liver Maximum Function Capacity Test, Fibrinogen, and Transient Elastography in Patients with Acute Liver Injury.
    Dig Dis. 2023;41:259-267.
    >> Share

  19. WANG B, Min W, Zhang W, Liu Q, et al
    PIK3R3 Missense and NOTCH2 Synonymous Single Nucleotide Polymorphisms Are Associated with Liver Cancer.
    Dig Dis. 2023;41:458-467.
    >> Share

  20. LIU W, Xu L, Xu F, Wang J, et al
    A Retrospective Analysis of the Efficacy of Endoscopic Variceal Ligation versus Endoscopic Tissue Adhesive Injection in the Treatment of Esophagogastric Variceal Bleeding.
    Dig Dis. 2023;41:468-475.
    >> Share

  21. FERRARI-CESTARI M, Okano S, Patel PJ, Horsfall LU, et al
    Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
    Dig Dis. 2023;41:439-446.
    >> Share

  22. PENG S, Wu Q, Huang X, He X, et al
    Diagnostic Value of Serum Golgi Protein 73 for Liver Fibrosis: A Systematic Review and Meta-Analysis.
    Dig Dis. 2023;41:622-631.
    >> Share

  23. ITZEL T, Falconer T, Roig A, Daza J, et al
    Efficacy of Co-Medications in Patients with Alcoholic Liver Disease.
    Dig Dis. 2023;41:780-788.
    >> Share

  24. LE MH, Henry L, Cheung R, Nguyen MH, et al
    Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis.
    Dig Dis. 2023;41:767-779.
    >> Share

  25. ANDROUTSAKOS T, Dimitriadis K, Revenas K, Vergadis C, et al
    Liver Biopsy: To Do or Not to Do - A Single-Center Study.
    Dig Dis. 2023;41:913-921.
    >> Share

  26. FU Z, Cheng P, Jian Q, Wang H, et al
    High Systemic Immune-Inflammation Index, Predicting Early Allograft Dysfunction, Indicates High 90-Day Mortality for Acute-On-Chronic Liver Failure after Liver Transplantation.
    Dig Dis. 2023;41:938-945.
    >> Share

    December 2022
  27. HOU J, Qiang Z, Li Y, Zhang Y, et al
    The different prognosis of hepatocellular carcinoma with previous tenofovir vs entecavir treatment for chronic hepatitis B virus: analysis based on 15 propensity score-matched studies.
    Dig Dis. 2022 Dec 19. doi: 10.1159/000528711.
    >> Share

    November 2022
  28. ZHANG Y, Cai H, Wu MH, Zhu DH, et al
    miR-3682-3p activated by c-Myc aggravates the migration and stemness in hepatocellular carcinoma cells by regulating PTEN/PI3K/AKT/beta-catenin signaling.
    Dig Dis. 2022 Nov 10. pii: 000527800. doi: 10.1159/000527800.
    >> Share

    October 2022
  29. WANG X, Zhang J, Luo F, Shen Y, et al
    Application of CircRNA Circ_0071662 in the diagnosis and prognosis of hepatocellular carcinoma and its response to radiotherapy.
    Dig Dis. 2022 Oct 24. pii: 000527696. doi: 10.1159/000527696.
    >> Share

  30. HONG C, Dong HZ, Li RN, Zhu HB, et al
    Predictive Value of the Hepatic Immune Predictive Index for Patients with Primary Liver Cancer Treated with Immune Checkpoint Inhibitors.
    Dig Dis. 2022 Oct 18. pii: 000527574. doi: 10.1159/000527574.
    >> Share

    May 2022
  31. CAO D, Liu H, Bai L, Tang H, et al
    EMT-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Hepatocellular Carcinoma.
    Dig Dis. 2022 May 30. pii: 000525232. doi: 10.1159/000525232.
    >> Share

    April 2022
  32. OP DEN WINKEL M, Nagel D, Seidensticker M, De Toni EN, et al
    Development and external validation of the Munich Sorafenib Evaluation Score for hepatocellular carcinoma.
    Dig Dis. 2022 Apr 14. pii: 000524336. doi: 10.1159/000524336.
    >> Share

    March 2022
  33. INUKAI Y, Yamamoto K, Honda T, Ito T, et al
    Differences in the intestinal microbiome associated with diarrhea during lenvatinib treatment for hepatocellular carcinoma.
    Dig Dis. 2022 Mar 28. pii: 000524298. doi: 10.1159/000524298.
    >> Share

  34. SHI L, Zhang S
    Identification of subclasses of decompensated cirrhotic patients with acute kidney injury with different responses to fluid input.
    Dig Dis. 2022 Mar 17. pii: 000524028. doi: 10.1159/000524028.
    >> Share

    February 2022
  35. JAHN M, Raschidi L, Ozcurumez MK, Arzideh F, et al
    Comparison of Mortality Prediction Scores in Intermediate-Care Patients with Liver Cirrhosis at a German university transplant Center; a prospective study.
    Dig Dis. 2022 Feb 16. pii: 000522595. doi: 10.1159/000522595.
    >> Share

  36. YAN J, Deng M, Wang Y, Zhu M, et al
    Transjugular intrahepatic portosystemic shunt for portal vein cavernous transformation: a systematic review and single-arm meta-analysis.
    Dig Dis. 2022 Feb 7. pii: 000522313. doi: 10.1159/000522313.
    >> Share

    January 2022
  37. MIJAC D, Krstic MN, Markovic AP, Popovic DD, et al
    Abnormal Liver Blood Tests: Primary Care Approach.
    Dig Dis. 2022;40:215-222.
    >> Share

  38. SEHGAL R, Kaur N, Ramakrishna G, Trehanpati N, et al
    Immune Surveillance by Myeloid-Derived Suppressor Cells in Liver Diseases.
    Dig Dis. 2022;40:301-312.
    >> Share

  39. GISZAS B, Weber M, Heidel FH, Reuken PA, et al
    Recurrent Upper Gastrointestinal Bleeding from Isolated Gastric Varices as Primary Symptom of Myelofibrosis: A Case Report on Combining Interventional and Pharmacologic Treatment Options.
    Dig Dis. 2022;40:530-534.
    >> Share

  40. KALAL CR, Maiwall R, Choudhary A, Premkumar M, et al
    Mannitol Is Comparable to Hypertonic Saline for Raised Intracranial Pressure in Acute Liver Failure (MAHAL Study): A Randomized Controlled Trial.
    Dig Dis. 2022;40:607-615.
    >> Share

  41. LEMMER P, Selbach N, Baars T, Porsch-Ozcurumez M, et al
    Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm.
    Dig Dis. 2022;40:644-653.
    >> Share

  42. MASIOR L, Grat M
    Primary Nonfunction and Early Allograft Dysfunction after Liver Transplantation.
    Dig Dis. 2022;40:766-776.
    >> Share

  43. GARRIDO I, Magalhaes A, Lopes J, Macedo G, et al
    Trastuzumab Emtansine-Induced Nodular Regenerative Hyperplasia: Is Dose Reduction Enough as a Preventable Measure?
    Dig Dis. 2022;40:787-792.
    >> Share

  44. KAM LY, Huang DQ, Teng MLP, Takahashi H, et al
    Clinical Profiles of Asians with NAFLD: A Systematic Review and Meta-Analysis.
    Dig Dis. 2022;40:734-744.
    >> Share

    November 2021
  45. SHAO X, Uojima H, Arai T, Ogawa Y, et al
    The risk of cirrhosis and its complications based on PNPLA3 rs738409 G allele frequency.
    Dig Dis. 2021 Nov 22. pii: 000521062. doi: 10.1159/000521062.
    >> Share

  46. CHEN LS, Lee SW, Yang SS, Tsai HJ, et al
    Advances in the era of direct-acting antivirals for hepatitis C in patients with unresectable hepatocellular carcinoma.
    Dig Dis. 2021 Nov 9. pii: 000520721. doi: 10.1159/000520721.
    >> Share

  47. DREWES R, Heinze C, Pech M, Powerski M, et al
    Apparent diffusion coefficient can predict therapy response of hepatocellular carcinoma to transcatheter arterial chemoembolization.
    Dig Dis. 2021 Nov 8. pii: 000520716. doi: 10.1159/000520716.
    >> Share

    October 2021
  48. REITER FP, Ben Khaled N, Ye L, Zhang C, et al
    Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State of the Art Review.
    Dig Dis. 2021 Oct 13. pii: 000520095. doi: 10.1159/000520095.
    >> Share

    July 2021
  49. OSWALD L, Nakanishi H, Kurosaki M, Kirino S, et al
    Plasma renin activity predicts prognosis and liver disease-related events in liver cirrhosis patients with ascites treated by tolvaptan.
    Dig Dis. 2021 Jul 30. pii: 000518099. doi: 10.1159/000518099.
    >> Share

  50. JUNGST C, Justinger C, Fischer J, Berg T, et al
    Common ABCB4 and ABCB11 genotypes are associated with idiopathic chronic cholestasis in adults.
    Dig Dis. 2021 Jul 6. pii: 000518203. doi: 10.1159/000518203.
    >> Share

    June 2021
  51. OCAL O, Rossler D, Ricke J, Seidensticker M, et al
    Advances in Diagnostic and Interventional Radiology in Hepatocellular Carcinoma.
    Dig Dis. 2021 Jun 29. pii: 000518101. doi: 10.1159/000518101.
    >> Share

  52. KUBOTA K, Uojima H, Shao X, Iwasaki S, et al
    Additional L-carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin.
    Dig Dis. 2021 Jun 28. pii: 000518067. doi: 10.1159/000518067.
    >> Share

  53. OP DEN WINKEL M, Nagel D, de la Torre Alaez MA, Hempe S, et al
    A simple prognostic scoring system for hepatocellular carcinoma treated with selective internal radiation therapy.
    Dig Dis. 2021 Jun 10. pii: 000517458. doi: 10.1159/000517458.
    >> Share

    May 2021
  54. KRSTIC MN, Mijac D, Tomasevic RS, Lukic S, et al
    Abnormal liver blood tests: Hepatologist approach.
    Dig Dis. 2021 May 10. pii: 000517110. doi: 10.1159/000517110.
    >> Share

    April 2021
  55. MEYER JJ, Dreyhaupt J, Schwerdel D, Ettrich TJ, et al
    Blood-based targeted metabolomics discriminate patients with alcoholic liver cirrhosis from those with non-cirrhotic liver damage: an explorative study.
    Dig Dis. 2021 Apr 16. pii: 000516488. doi: 10.1159/000516488.
    >> Share

  56. MANZHALII E, Falalyeyeva TM, Moyseyenko VO, Weiskirchen R, et al
    Elevation of autoantibodies to cerebral proteins in hepatic encephalopathy: Another pathogenic factor?
    Dig Dis. 2021 Apr 9. pii: 000516412. doi: 10.1159/000516412.
    >> Share

    January 2021
  57. WEBER S, Benesic A, Buchholtz ML, Rotter I, et al
    Antimitochondrial Rather than Antinuclear Antibodies Correlate with Severe Drug-Induced Liver Injury.
    Dig Dis. 2021;39:275-282.
    >> Share

  58. XU Y, Hu X, Li J, Dong R, et al
    An Improved Scoring System Based on Platelet-Albumin-Bilirubin in Predicting Posthepatectomy Liver Failure Outcomes.
    Dig Dis. 2021;39:258-265.
    >> Share

  59. WADA N, Uojima H, Satoh T, Okina S, et al
    Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.
    Dig Dis. 2021;39:234-242.
    >> Share

  60. PARK J, Lee EY, Li J, Jun MJ, et al
    NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.
    Dig Dis. 2021;39:634-645.
    >> Share

  61. YAMAMOTO K, Ikeya T, Okuyama S, Fukuda K, et al
    Association between the Frequency of Daily Toothbrushing and Development of Nonalcoholic Fatty Liver Disease.
    Dig Dis. 2021;39:646-652.
    >> Share

  62. FREITAS M, Macedo Silva V, Xavier S, Magalhaes J, et al
    Early Kidney Dysfunction in Metabolic-Associated Fatty Liver Disease: Is Transient Elastography Useful as a Screening Method?
    Dig Dis. 2021;39:653-662.
    >> Share

  63. ATTA S, Kamel M, Mansour W, Hussein T, et al
    Ascitic Fluid Cytokines in Chronic Liver Disease: A Possible Prognostic Tool.
    Dig Dis. 2021;39:534-539.
    >> Share

    November 2020
  64. SCHINDLER P, Masthoff M, Harders F, Schmidt H, et al
    EFFICACY OF 90Y-RADIOEMBOLIZATION IN METASTATIC COLORECTAL CANCER DEPENDING ON THE PRIMARY TUMOR SIDE.
    Dig Dis. 2020 Nov 3. pii: 000512744. doi: 10.1159/000512744.
    >> Share

    September 2020
  65. BARABAS L, Hritz I, Istvan G, Tulassay Z, et al
    The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
    Dig Dis. 2020 Sep 22. pii: 000511765. doi: 10.1159/000511765.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016